Elevated leptin levels are thought to be involved in tumour cell growth and invasion through increased expression of vascular endothelial growth factor (VEGF) and by modulating the oestrogen receptor α (ERα), which stimulates aromatase expression and consequently increases oestrogen levels [12,13]. This evidence concerns the gene CYP19A1 and neoplasm.